Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

A request for proprietary name review for REYOBIQ™ must be submitted once the marketing application (NDA) is submitted ... award from the National Cancer Institute (NCI), part of the U.S ...

Bharatiya Janata Party on Thursday issued a three-line whip to all of its Lok Sabha MPs asking them to be present in the ...

Their first tracker is now in orbit. They plan to use a series of these to generate live maps of satellites big and small, fragments from old vessels, and debris as small as 5 cm.

REYOBIQ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and Recurrent Glioblastoma (GBM) HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus ...

Story continues below this ad A computer science graduate from the Birla Institute of Technology, Mesra, he had been understood to be reluctant to join politics till now. But the speculation around ...

Mumbai: At the Tata Institute of Social Sciences, student organisations are protesting to demand clarity on the admission ...

Ara: Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) commissioner-cum-additional chief executive officer ...

Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...

Experts at MIT and Nvidia created a hybrid approach for AI image generation that takes far less computation resources while ...